PGY2 Infectious Disease Pharmacy

The PGY2 pharmacy residency program in infectious diseases builds upon the Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area.

The Yale New Haven Hospital (YNHH) PGY2 infectious diseases pharmacy residency program prepares its graduates to assume positions in infectious diseases as clinical specialists employed by an institution or as assistant professors at a college of pharmacy. YNHH is a university teaching hospital that provides residents unique rotation opportunities with oncology (including bone marrow transplant), solid organ transplant, intensive care units, and antimicrobial stewardship. Our residents will have the opportunity for direct patient care activities, research, administration, project management and precepting learners. 

The PGY-2 year consists of a series of learning experiences that span a 52 week period. Specific learning experiences and goals will be accomplished in discrete blocks of time, while others will occur longitudinally throughout the duration of the residency. Residency time will be generally structured as follows:

Required Rotational Experiences 

Elective Rotations: 4 weeks 

• Pediatric Infectious Diseases
• Emergency Department
• Cardiothoracic ICU
• Other (with residency director approval)
• Repeat (with residency director approval)

Longitudinal Experiences

1. Staffing*
   • Every 3rd weekend and 20 days of staffing in infectious diseases related shifts over the course of the residency year (12 day stretches required) 
   • On call formulary pager coverage (schedule to be determined)
     *Any shift including night shift may be filled at discretion of Residency Director
2. Residency project (Project Management): submit research project for Infectious Diseases Week annual meeting and publication to infectious diseases or pharmacy journal
3. Adult HIV ambulatory services/infectious diseases ambulatory clinic
4. Administrative reports/responsibilities
   • Participate on the System Antimicrobial Stewardship Committee (a subcommittee of the hospital’s Pharmacy & Therapeutics Committee)
   • Participate on the Infection Control meeting 
   • Assume independent responsibility for specific report(s)
   • Assist in precepting PGY-1 residents 
5. Non-formulary/Restricted/Rapid-diagnostics Pager Process
6. Drug Information/Education/Presentations
   • Department publications
   • Nursing and Physician Inservices
   • Clinical Case Conference (pharmacy department conference)
   • Pharmacy Grand Rounds
   • PharmD. students and residents (precept/lead discussions)
   • Journal club Presentations 

PGY2 Infectious Disease Requirements for Successful Graduation

1. Educational checklist complete
   a. Pharmacy Grand Rounds (1 hour presentation)
   b. Clinical Case Conference (1 20 minute presentations)
   c. Nursing In-services (2)
   d. Physician In-services (1)
   e. Pharmacist In-service (1)
   f. University level didactic lecture at School of Pharmacy or other health professional students (1)
   g. Community Service (2)
   h. Journal Club (4)
   i. Monograph/Class Review (1)
   j. Policy, Protocol or Guideline (1)
   k. Department Bulletin/Publication (1)
   l. Manuscript (1) (see below)
2. Portfolio complete (Completed documents for each checklist item uploaded to resident portfolio)
3. Quality Improvemnt/longitudinal project completed 
4. Achieved at least 80% of ASHP residency objectives (Preceptor marked as "achieved" on at least two occasions or other documentation demonstrating achievement of the objective as evaluated by the RPC/RPD)
5. Abstract submission and/or poster or platform presentation at local or national meeting such as ID week, ASM Microbe, Midyear, etc. as approved by RPD
6. Manuscript suitable for publication (Complete manuscript incorporating at least two rounds of preceptor feedback)
7. Compliant with all pharmacist mandatory requirements (e.g. current pharmacist license in good standing on file, completion of all mandatory training)

Residency Leadership

• Dayna McManus, PharmD, BCPS, BCIDP
  Pharmacy Manager, Infectious Diseases and Solid Organ Transplant
  Director, PGY-2 Infectious Diseases Pharmacy Residency
  [email protected]
  
  
• Natalie Tucker, PharmD, BCIDP
  Clinical Pharmacist, Infectious Diseases/Antimicrobial Stewardship
  Coordinator, PGY-2 Infectious Diseases Pharmacy Residency
  [email protected]
  
  
• Bailey Thayer, PharmD, AAHIVP, BCIDP 
  Clinical Pharmacist, Infectious Diseases/Antimicrobial Stewardship
  Coordinator, PGY-2 Infectious Diseases Pharmacy Residency
  [email protected]

The learning experiences will include a series of learning activities designed to expose the resident to many facets of pharmacy practice with guidance from the preceptor. An individual resident plan and calendar will be developed for each resident.

This residency site agrees that no person at this site will solicit, accept, or use any ranking-related information from any residency applicant.

Note: We are unable to accept applicants with F1 status/OPTs and unable to sponsor F1-B visas at this time.